"There is a clear association between the use of GLPs and increased risks of food retention during upper endoscopy," Mathur ...

The pharma company said it believes there’s plenty of room for multiple industry players in the obesity drug market.

Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy ...

A new analysis points to troubling trends in the U.S. healthcare market as costs continue to rise but health outcomes are ...

The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the ...

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the weight loss ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

Why a Malvern biopharma is exploring combining its lead drug candidate targeting Alzheimer's and Parkinson's diseases with a ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review: ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, we are going to take a look ...